Bristol-Myers Squibb (BMY) Completes Tender Offer for Medarex (MEDX)
Bristol-Myers Squibb Company (NYSE: BMY) announced that the depositary for its tender offer for all the outstanding common stock of Medarex has advised that, as of the expiration of the subsequent offering period, shareholders of Medarex, Inc. (NASDAQ: MEDX) tendered approximately 120,417,467 shares, representing, together with the 2,879,223 shares of Medarex common stock owned by Bristol-Myers Squibb since January 2005, approximately 90.7% of the Medarex shares outstanding.
You May Also Be Interested In
- Patriot Coal (PCX) CEO Whiting Issues Employee Letter
- UPDATE: Eaton (ETN) to Buy Cooper Industries (CBE) in Cash, Stock Deal Valued at $72/Share
- FINRA says claims Morgan Stanley (MS) reduced outlook on Facebook (FB) ahead of IPO will be probed -Reuters
Create E-mail Alert Related Categories
Corporate News, Mergers and AcquisitionsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
